Evaluation of the MicroScan Urinary Combo Panel and API 20E system for identification of glucose-nonfermenting gram-negative bacilli isolated from clinical veterinary materials.
Many isolates of glucose-nonfermenting gram-negative bacilli (NFB) cultured from clinical veterinary specimens are not identified because of the large number of identification tests required. We evaluated two commercial identification systems to determine if they could accurately identify NFB isolated from animals. Of 182 strains of NFB, the MicroScan Urinary Combo Panel (MicroScan, Inc., Campbell, Calif.) correctly identified 72%, and the API 20E system (Analytab Products, Plainview, N.Y.) correctly identified 74%. Of the 118 strains of the three most common species of NFB isolated from animals, the MicroScan Urinary Combo Panel identified 86% correctly, and the API 20E system identified 92% correctly. The use of either of these systems could improve the accuracy of identification of NFB from clinical veterinary materials.
D000820:Animal Diseases / Q000382:microbiology*; D000818:Animals; D001419:Bacteria / Q000302:isolation & purification*; D001431:Bacteriological Techniques; D005285:Fermentation; D005947:Glucose / Q000378:metabolism*; D011933:Reagent Kits, Diagnostic
D011933:Reagent Kits, Diagnostic; D005947:Glucose